Top Clinical Trials companies in the world by Interest Coverage Ratio

This ranking features the top 356 Clinical Trials companies in the world ranked by Interest Coverage Ratio, averaging a Interest Coverage Ratio of -782.86, for January 15, 2025.

Global

Clinical Trials

#	Name	Interest Coverage Ratio	Reported Date	Stock Price	Change	Country
1	Alar Pharmaceuticals Inc. 1 6785.TWO	6,209.03	Dec. 31, 2023	USD 4.09	5.18%
2	Reviva Pharmaceuticals Holdings, Inc. 2 RVPH	3,928.82	Sept. 30, 2024	USD 1.58	-17.28%	United States
3	StemRIM 3 4599.T	2,935.57	July 31, 2023	USD 1.94	-0.83%	Japan
4	BioNTech SE 4 22UA.F	1,586.49	Dec. 31, 2023	USD 116.36	-0.45%	Germany
5	BioArctic AB (publ) 5 BIOA-B.ST	730.51	Dec. 31, 2023	USD 17.87	3.09%	Sweden
6	Neurocrine Biosciences, Inc. 6 NBIX	267.41	Sept. 30, 2024	USD 139.51	-2.46%	United States
7	Genmab A/S 7 GMAB.CO	209.78	Dec. 31, 2023	USD 216.88	1.28%	Denmark
8	Joinn Laboratories(China)Co.,Ltd. 8 6127.HK	148.25	Dec. 31, 2023	USD 1.06	2.98%	China
9	HUTCHMED (China) Limited 9 0013.HK	77.82	Dec. 31, 2023	USD 3.02	2.59%	Hong Kong
10	Inhibrx Biosciences, Inc. 10 INBX	76.16	Sept. 30, 2024	USD 12.74	-6.60%	United States
11	Protagonist Therapeutics, Inc. 11 PTGX	64.56	Sept. 30, 2024	USD 36.67	-1.26%	United States
12	hVIVO plc 12 HVO.L	64.22	Dec. 31, 2023	USD 0.21	6.16%	United Kingdom
13	Shin Nippon Biomedical Laboratories, Ltd. 13 2395.T	51.25	March 31, 2024	USD 10.78	1.91%	Japan
14	Incyte Corporation 14 INCY	49.58	Sept. 30, 2024	USD 71.93	-0.61%	United States
15	Corcept Therapeutics Incorporated 15 CORT	39.82	Sept. 30, 2024	USD 51.66	1.18%	United States
16	Vimta Labs Limited 16 VIMTALABS.NS	37.01	March 31, 2024	USD 10.54	-1.07%	India
17	Medpace Holdings, Inc. 17 MEDP	36.34	Sept. 30, 2024	USD 330.91	-5.99%	United States
18	Mega Genomics Limited 18 6667.HK	33.25	Dec. 31, 2023	USD 1.18	-0.89%	China
19	Castle Biosciences, Inc. 19 CSTL	23.87	Sept. 30, 2024	USD 25.46	-2.64%	United States
20	Akeso, Inc. 20 9926.HK	23.33	Dec. 31, 2023	USD 7.28	2.32%	China
21	Exelixis, Inc. 21 EXEL	23.13	Sept. 27, 2024	USD 35.65	0.99%	United States
22	Hangzhou Tigermed Consulting Co., Ltd. 22 3347.HK	21.76	Dec. 31, 2023	USD 3.72	2.09%	China
23	PhoenixBio Co., Ltd. 23 6190.T	21.43	March 31, 2024	USD 2.06	-4.87%	Japan
24	GNI Group Ltd. 24 2160.T	11.10	Dec. 31, 2023	USD 19.77	1.11%	Japan
25	Vertex Pharmaceuticals Incorporated 25 VRTX	7.76	Sept. 30, 2024	USD 411.66	-0.41%	United States
26	HBM Holdings Limited 26 2142.HK	6.86	Dec. 31, 2023	USD 0.34	-0.77%	China
27	Precision BioSciences, Inc. 27 DTIL	6.83	Sept. 30, 2024	USD 5.38	-6.27%	United States
28	Supernus Pharmaceuticals, Inc. 28 SUPN	6.82	March 31, 2024	USD 37.82	0.66%	United States
29	Sarepta Therapeutics, Inc. 29 SRPT	6.76	Sept. 30, 2024	USD 118.83	0.34%	United States
30	Kindstar Globalgene Technology, Inc. 30 9960.HK	6.39	Dec. 31, 2023	USD 0.15	-0.02%	China
31	Shanghai Henlius Biotech, Inc. 31 2696.HK	5.71	Dec. 31, 2023	USD 2.59	-10.24%	China
32	Charles River Laboratories International, Inc. 32 CRL	4.94	Sept. 28, 2024	USD 178.08	-6.34%	United States
33	ICON Public Limited Company 33 ICLR	2.78	Dec. 31, 2023	USD 200.24	-8.14%	Ireland
34	CytomX Therapeutics, Inc. 34 CTMX	2.67	Sept. 30, 2024	USD 0.84	-5.23%	United States
35	Australian Clinical Labs Limited 35 ACL.AX	2.42	June 30, 2024	USD 2.14	0.82%	Australia
36	Rigel Pharmaceuticals, Inc. 36 RIGL	1.42	Sept. 30, 2024	USD 16.69	-2.46%	United States
37	Oramed Pharmaceuticals Inc. 37 ORMP	1.41	Sept. 30, 2024	USD 2.36	NA	United States
38	Telix Pharmaceuticals Limited 38 TLX.AX	1.24	Dec. 31, 2023	USD 15.47	4.25%	Australia
39	TG Therapeutics, Inc. 39 TGTX	0.29	Sept. 30, 2024	USD 29.74	7.48%	United States
40	Capricor Therapeutics, Inc. 40 CAPR	-0.06	Dec. 31, 2023	USD 12.59	-1.02%	United States
41	InMed Pharmaceuticals Inc. 41 INM	-0.09	March 31, 2024	USD 4.08	-3.32%	Canada
42	ABL Bio Inc. 42 298380.KQ	-0.23	Dec. 31, 2023	USD 21.07	1.40%	South Korea
43	Agenus Inc. 43 AGEN	-0.66	Sept. 30, 2024	USD 3.15	-0.32%	United States
44	Avacta Group Plc 44 AVCT.L	-0.73	Dec. 31, 2023	USD 0.62	-2.80%	United Kingdom
45	Lepu Biopharma Co., Ltd. 45 2157.HK	-1.06	Dec. 31, 2023	USD 0.31	4.82%	China
46	Xeris Biopharma Holdings, Inc. 46 XERS	-1.20	Sept. 30, 2024	USD 3.20	-2.44%	United States
47	Alnylam Pharmaceuticals, Inc. 47 ALNY	-1.39	Sept. 30, 2024	USD 240.51	-6.88%	United States
48	Sangamo Therapeutics, Inc. 48 SGMO	-1.54	Dec. 31, 2023	USD 1.02	-5.56%	United States
49	Adverum Biotechnologies, Inc. 49 ADVM	-1.59	Sept. 30, 2023	USD 4.25	1.19%	United States
50	PureTech Health plc 50 PRTC.L	-1.68	Dec. 31, 2023	USD 1.72	1.09%	United States

1 2 3 4 … 8

Frequently Asked Questions

Which Clinical Trials company has the highest Interest Coverage Ratio ?

The Clinical Trials company with the highest Interest Coverage Ratio is Alar Pharmaceuticals Inc. (Taipei Exchange: 6785.TWO) at 6,209.03.
Which Clinical Trials company has the lowest Interest Coverage Ratio ?

The Clinical Trials company with the lowest Interest Coverage Ratio is Synlogic, Inc. (NasdaqCM: SYBX) at -57,267.00.

What are the top 10 Clinical Trials companies by Interest Coverage Ratio ?

The top 10 Clinical Trials companies the Global by Interest Coverage Ratio are Alar Pharmaceuticals Inc., Reviva Pharmaceuticals Holdings, Inc., StemRIM, BioNTech SE, BioArctic AB (publ), Neurocrine Biosciences, Inc., Genmab A/S, Joinn Laboratories(China)Co.,Ltd., HUTCHMED (China) Limited and Inhibrx Biosciences, Inc..
What are the bottom 10 Clinical Trials companies by Interest Coverage Ratio ?

The bottom 10 Clinical Trials companies by Interest Coverage Ratio are Synlogic, Inc., Kodiak Sciences Inc., NextCell Pharma AB, ESSA Pharma Inc., GT Biopharma, Inc., ProKidney Corp., Altimmune, Inc., CombiGene AB (publ), Trevi Therapeutics, Inc. and VistaGen Therapeutics, Inc..